~Aims to generate Rs 50 crores revenue by the end of 2021 with this launch
~The product is intended for people with weakened immunity
New Delhi, NFAPost: Amway India, one of the country’s leading FMCG direct selling companies, announced the launch of its Nutrilite Vitamin C Cherry Plus intended for individuals with weakened immunity that comes with the benefit of extended-release technology.
With this, Amway India is further strengthening its nutrition and immunity supporting portfolio in the country by introducing a product for special dietary use for individuals with weakened immunity.
The Nutrilite Vitamin C Cherry Plus provides steady release of Vitamin C into the body for over 8 hours as it is formulated with Extended-Release technology, to provide all-day immune support.
Immunity needs
Commenting on the category, Amway India CEO Anshu Budhraja said today the company finds itslef reprioritizing nutrition and immunity needs as Amway continues to fight this pandemic while making appropriate lifestyle changes.
“In the recent times we noticed, health-conscious and individuals with weakened immunity have shifted to preventive and smart healthcare to support their immunity and safeguard themselves. The global health crisis has resulted in a spike in demand for health and nutrition supplements and Vitamin C is one of them as it is known for its immunity supporting properties,” said Anshu Budhraja.
Anshu Budhraja also said adults Vitamin C market in India was close to Rs 185 crores in 2020 and is growing with CAGR of 15%. L”ooking at the growth trend and with the extension of our existing range of products under the nutrition and immunity category, with Nutrilite Vitamin C Cherry Plus targeted for population with specific need we are targeting to generate more than 100 Crores in revenue by 2025,” said Anshu Budhraja.
Vitamin supplements
Further adding to the launch, Amway India CMO Ajay Khanna said as per a recent survey, 50% of consumers reported taking more supplements to support their immune system in 2020 and the trend is here to remain for a longer period of time.
“Vitamin C is known to provide immunity supporting benefits along with its known antioxidant properties. Nutrilite’s new Vitamin C Cherry Plus provides slow, steady release of Vitamin C in the body for 8 hours as it is formulated with extended-release technology for improved utilization of Vitamin C for an all-day immunity support,” said Ajay Khanna.
Ajay Khanna said the product is made with the plant-based source of Vitamin C like Acerola Cherries, which are one of nature’s most concentrated sources of Vitamin C grown in our own organic farms in Brazil. “This product is intended for those adults who have a weakened immunity,” he said.
Organic farms
Amway sources ingredients for its Nutrilite range of dietary supplements from certified organic farms. Nutrilite ensures growing, harvesting and processing plants on certified partner organic farms from various parts of the country.
The company has a comprehensive traceability plan which tracks the entire journey of seed to supplement ensuring that only the highest quality ingredients go into Nutrilite products. Nutrilite products offer assured levels of Purity, Safety, and Potency and are backed by Amway’s strong legacy of scientific research, making them an effective way to maintain one’s health.
About Nutrilite Vitamin C Cherry Plus:
• Made with the plant-based source of Vitamin C like Acerola Cherries, which are one of nature’s most concentrated sources of Vitamin C grown in our own organic farms in Brazil.
• A daily serving of one Nutrilite Vitamin C Cherry Plus tablet provides Vitamin C (400 mg) equivalent to 9 oranges or 8 lemons . Priced at MRP of INR 1200.00 (incl. of all taxes), Nutrilite Vitamin C Cherry Plus will be sold exclusively by Amway Direct Sellers/Retailers across India and to know more, visit the company’s website www.amway.in.
• The extended-release technology in these tablets is one of its kind currently available in the market which makes Nutrilite Vitamin C Cherry Plus the first product in the category with this mechanism for individuals with weakened immunity.
